Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Study of Epivir's effect on HIV survival and disease progression terminated

Aug. 9, 1996

Emory University issued U.S. patent covering Epivir

Aug. 9, 1996

Vistide available in U.S. as CMV treatment in AIDS patients

July 26, 1996

rBCG-V3JI: Ajinomoto's vector-based vaccine

July 26, 1996

Immunogenic oligomeric HIV-1 gp160 vaccine described

July 26, 1996

Rz9456: Potential hematopoietic stem cell therapy for AIDS

July 26, 1996

Cyanovirin-N selected for high priority development by the National Cancer Institute

July 26, 1996

CHAM3 induces clinical and biological improvement in HIV patients

July 26, 1996

ZY-1 demonstrates therapeutic promise in HIV patients

July 26, 1996

TAR-PAK-140: University of Alberta's anti-HIV vector

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...